Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty
(Reuters) -Zimmer Biomet Holdings on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28, currency volatility, and proposed tariffs.
Investors and analysts are closely monitoring how medical device makers will handle any impact from the Trump administration’s tariffs and whether they expect benefits from foreign currency fluctuations.
Earlier this year, Zimmer said that it would acquire medical device firm Paragon 28 for $1.1 billion, to expand its portfolio of orthopedic surgical devices.
Zimmer expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior view of $8.15 to $8.35 per share. Analysts were expecting annual profit of $8.19 per share, according to data compiled by LSEG.
The Warsaw, Indiana-based company expects currency swings to have a negligible to marginally positive effect on its 2025 revenue, revising its initial forecast of a 1.5% to 2% negative impact to a range of 0% to 0.5%.
Last week, peer Stryker Corp (NYSE:SYK) reduced its 2025 profit outlook and said it anticipated a $200 million tariff impact in the year.
However, Zimmer’s first-quarter profit and revenue both came in slightly above expectations, due to strong demand for its devices used in hip and knee procedures.
Combined sales at Zimmer’s hips and knees units came in at $1.29 billion, compared to $1.28 billion, a year ago.
Zimmer’s first-quarter revenue came in at $1.91 billion, slightly ahead of estimates of $1.90 billion.
ZBH: A Bull or Bear Market Play?
Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year..
In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record.
With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies.
So if ZBH is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.
